Outsourcing Pharma
JANUARY 12, 2022
The company plans to launch a Phase Ib/II study of its compound NVG-291 in collaboration with researchers at Northwestern Universityâs Shirley Ryan AbilityLab.
pharmaphorum
JANUARY 12, 2022
Roche has launched what it says is a first-of-its kind handheld glucose management device, backed up by a digital platform that aims to simplify the work of doctors and nurses as they deliver care to patients. The cobas pulse system is a point-of-care device that combines a glucose test strip reader with a touch screen that is used for displaying patient information and data, as well as analysing and sharing clinical results.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
JANUARY 12, 2022
JPM22, Day 3: Signify Health rolls out partnership program, BCBS Massachusetts exec talks tackling health inequity and more. hlandi. Wed, 01/12/2022 - 08:11.
pharmaphorum
JANUARY 12, 2022
The development of gene therapies for Duchenne muscular dystrophy has proved to be challenging, but one of the key players – Sarepta – thinks it may have the clinical data needed to file for regulator approval. The new data from the mid-stage Study 102 of SRP-9001 (delandistrogene moxeparvovec) comes from 21 patients who were initially in the placebo group of the study but crossed over to receive the gene therapy later.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
JANUARY 12, 2022
Hospitals urge Biden, Becerra to extend emergency declarations as hospitalizations reach pandemic highs. dmuoio. Wed, 01/12/2022 - 14:53.
pharmaphorum
JANUARY 12, 2022
Prospects for Aldeyra’s dry eye disease candidate reproxalap were hit last month after the drug failed to hit its primary objective in a phase 3 trial, but the company isn’t giving up and has new data showing an improvement over Novartis rival therapy Xiidra. Patients treated with reproxalap reported significantly less eye discomfort and itching than those using Xiidra (lifitegrast) in the new phase 2 trial, which Aldeyra said backs up early tolerability comparisons between the drugs
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
JANUARY 12, 2022
EMA “lags behind” other international regulators when it comes to approval timelines, finds EFPIA analysis. Only a regulatory framework that “embraces a culture of excellence and innovation” will make Europe a world leader in life sciences and ensure people can reap the benefits of life-changing new treatments. That’s according to the EFPIA’s analysis of the region’s regulatory framework, which compares the timelines of national regulatory agencies, and suggests key areas for change as the Europ
Fierce Healthcare
JANUARY 12, 2022
Headspace Health grabs startup Sayana to build out AI-based mental health tools. hlandi. Wed, 01/12/2022 - 12:18.
pharmaphorum
JANUARY 12, 2022
The pandemic has given us a surge of opportunities to take fresh looks at how we live, work and play with huge changes of pace and direction being funnelled through technology. Digital muscled its way to centre stage as we plunged into lockdowns and its life and sanity-saving qualities were immediately clear. It also helped most businesses to function but two years on we need to re-focus.
Fierce Healthcare
JANUARY 12, 2022
HCA, Eli Lilly, Atrium Health back $55M venture fund to invest in Black-founded and -led health startups. hlandi. Wed, 01/12/2022 - 10:37.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
JANUARY 12, 2022
Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It’s the end of the road for the South San Francisco-based company, which became part of the Daiichi Sankyo in a $935 million deal in 2011 and since then has contributed two approved cancer therapies – Zelboraf (vemurafenib) for melanoma and Turalio (pexidartinib) for tenosynovial giant cell tumour
Fierce Healthcare
JANUARY 12, 2022
Maternal health startup Diana Health lands $11M to open first location in partnership with HCA Healthcare. agliadkovskaya. Wed, 01/12/2022 - 11:31.
Outsourcing Pharma
JANUARY 12, 2022
The pharma firm and collaborator Molecular Partners reported positive data out of their Phase II study for ensovibep, an antiviral for treating the virus.
Fierce Healthcare
JANUARY 12, 2022
OSF Ventures launches $100M innovation investment fund, its largest to date. dmuoio. Wed, 01/12/2022 - 12:02.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
JANUARY 12, 2022
Formedix and CDISC Join Forces to Provide Free Access to Ready-to-Use, CDASH-Compliant eCRFs for Accelerated Clinical Trial Set-Up. Formedix, a leading provider of clinical trial software solutions, has collaborated with CDISC, the global clinical research data standards development organization, to create a novel portal providing free access to ready-to-use, CDASH-compliant, annotated electronic case report forms (eCRFs).
Fierce Healthcare
JANUARY 12, 2022
Insurers applaud CMS' proposal for Medicare to only cover Aduhelm for seniors in clinical trials. rking. Wed, 01/12/2022 - 17:20.
pharmaphorum
JANUARY 12, 2022
Rewind to late 2019. If you had been told that within a few months, you’d be living in the middle of the biggest pandemic since the 1918 global flu outbreak, but that thanks to new mRNA technology, vaccine prototypes would be ready for trials within weeks and the first shots would go into arms before the end of 2020, what would you have thought? You could be forgiven for assuming that people would marvel in unison about the miracle of modern medical science.
Fierce Healthcare
JANUARY 12, 2022
JPM 2022: Morgan Health, Kaiser Permanente partner on health equity. pminemyer. Wed, 01/12/2022 - 12:53.
pharmaphorum
JANUARY 12, 2022
Biogen’s difficult launch of controversial Alzheimer’s therapy Aduhelm has been made even harder by a proposal by Medicare to cover the drug only for certain patients enrolled in clinical trials. Biogen and partner Eisai had been hoping for good news from the review of Aduhelm (aducanumab) by the Centre for Medicare and Medicaid Services (CMS), but the draft decision means broad coverage of the drug will have to wait for the outcome of ongoing studies before it can hope for broader c
Fierce Healthcare
JANUARY 12, 2022
Providers want more training, resources on managing medical waste, survey finds. agliadkovskaya. Wed, 01/12/2022 - 15:47.
Druggist
JANUARY 12, 2022
Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image). The post Product Image (name: product-image) appeared first on Druggist.Online.
Fierce Healthcare
JANUARY 12, 2022
JPM 2022: Clover Health's MA enrollment spikes 25% from 2021. pminemyer. Wed, 01/12/2022 - 10:12.
Med Ed 101
JANUARY 12, 2022
The American Diabetes Association released their 2022 Diabetes Guidelines update. While I wouldn’t call the changes earth-shattering, there are some items in relation to pharmacotherapy that I feel are really important to note. The patient population that I work with the most is those who have Type 2 diabetes. The beneficial data in cardiovascular, heart […].
Pharma Times
JANUARY 12, 2022
Under current guidelines, individuals that test positive for COVID-19 may be able to leave self-isolation after 7 days if certain conditions are met.
Pharma Times
JANUARY 12, 2022
The test is hoped to provide patients with a more convenient means of access to treatment for respiratory issues.
Expert insights. Personalized for you.
145 
Let's personalize your content